Viruses multiplication cycle

The eclipse is the period during which the stages of virus multiplication occur. This is called the latent period, because no infectious virus particles are evident. Finally, maturation begins as the newly synthesized nucleic acid molecules become assembled inside protein coats. During the maturation phase, the titer of active virus particles inside the cell rises dramatically. At the end of maturation, release of mature virus particles occurs, either as a result of cell lysis or because of some budding or excretion process. The number of virus particles released, called the burst size, will vary with the particular virus and the particular host cell, and can range from a few to a few thousand. The timing of this overall virus replication cycle varies from 20-30 minutes in many bacterial viruses to 8-40 hours in most animal viruses. We now consider each of the steps of the virus multiplication cycle in more detail. 

A sulfated polymaimuroguluronate (Fig. 7B) isolated from Laminaria japon-ica [120] and a sulfated xylomannan isolated from Scinaia hatei [121] inhibited HIV and HSV, respectively. The compounds interfered with the virus multiplication cycle. 

The objective of viral replication is to ensure the multiplication of the virus by formation of virions (virus progeny) identical to the parent strain. Because of the structure of a virus, the multiplication cycle focuses mainly on the replication of viral DNAorRNA. 

The progress made in cell culture techniques has provided a better understanding of viral replication cycles. Human viruses generally have a slow multiplication cycle requiring from 4 to more than 40 hours (in some herpesviruses) for completion this contrasts with bacterial viruses (bacteriophages) with a replication cycle as fast as 30 minutes. Certain viruses exhibit low infectivity for example, pi-cornavirus infectivity can be as low as 0.1% and rotavirus about 0.2%, and this makes the study of viral replication difficult. 

The pharmacokinetics and pharmacodynamics of recombinant interleukin-2 (IL-2) in patients with human immunodeficiency virus (HIV) infection have been evaluated (75). Patients were administered IL-2 either by continuous infusion or by SC injection for 5 days over multiple cycles. Following repeated injection, soluble IL-2 receptors were substantially but transiently increased. A dose-dependent decrease in area under the concentration-time curve (AUC) between days 1 and 5 was attributed to a receptor-mediated change in clearance. Concentrations were described using an unusual model that employed an indirect stimulatory PD model to link the time-dependent changes of the pharmacokinetics with the change in IL-2 receptor density following repeated administration. 

The progression of viral mRNA production during the infection cycle was characterized by means of qPCR measurements. MDCK cells infected with influenza A/PR/8 virus (multiplicity of infection = 100 one cell is virtually infected by 100 virus particles) were harvested at various points post infection. Noninfected cells were collected for control experiments. The total RNA was isolated and purified by using commercially available kits. The optical density (OD) of isolated RNA was measured and aliquots were subjected to in vitro transcription. After quantification (by OD measurements), the resulting complementary deoxyribonucleic acid (cDNA) was analyzed in qPCR experiments. 

Table 6. Phosphorylation of P67 in interferon-treated mengo virus infected cells during the viral multiplication cycle.

Zarbl, H., and Millward, S., 1983, The reovirus multiplication cycle, in The Viruses, The Reoviridae (H. Fraenkel-Conrat and R. Wagner, eds.), pp. 107-196, Plenum Press, New York. 

The number of myristoylated proteins identified in viruses is constantly increasing. Nevertheless, substantial additional work will be required to shed light on the multiple functions that could be executed by the respective proteins as well as their involvement in the viral life cycle and elucidation of the role of the lipid anchor. Inhibition of NMT or replacing myristic acid by analogs in infected cells is known to affect numerous viruses of medical importance, for example, HIV (Bryant et al. 1989), hepatitis B virus (Parang et al. 1997), herpesviruses (Harper et al. 1993), and... 

In order to study the virus growth curve a one-step growth cycle is performed. A high multiplicity of infection (m.o.i.) is used to ensure every cell is infected — usually 10 plaque forming units (p.f.u.) per cell is adequate. For virus production, however, the infection is prolonged under conditions where secondary infection can occur and a low m.o.i. is recommended especially where there is a tendency for defective virus particles to be produced. 

---